FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2954071372> ?p ?o ?g. }

• W2954071372 abstract "In spite of the major advantages that the liquisolid technology offers, particularly in tackling poor bioavailability of poorly water-soluble drugs (i.e., BCS Class II drugs), there are a few critical drawbacks. The inability of a high liquid load factor, poor flowability, poor compactibility, and an inability to produce a high dose dosage form of a reasonable size for swallowing are major hurdles, hampering this technology from being commercially feasible. An attempt was therefore made to overcome these drawbacks whilst maintaining the liquisolid inherent advantages. This resulted in the emerging next generation of oral dosage forms called the liqui-pellet. All formulations were incorporated into capsules as the final product. Solubility studies of naproxen were conducted in different liquid vehicles, namely polyethylene glycol 200, propylene glycol, Tween 80, Labrafil, Labrasol, and Kolliphor EL. The scanning electron microscopy studies indicated that the liquid vehicle tends to reduce the surface roughness of the pellet. X-ray powder diffraction (XRPD) indicated no significant differences in the crystalline structure or amorphous content between the physical mixture and the liqui-pellet formulation. This was due to the presence of a high concentration of amorphous Avicel in the formulation which overshadowed the crystalline structure of naproxen in the physical mixtures. Flowability and dissolution tests confirmed that this next-generation oral dosage form has excellent flowability, whilst maintaining the typical liquisolid enhanced drug release performance in comparison to its physical mixture counterpart. The liqui-pellet also had a high liquid load factor of 1, where ~ 29% of the total mass was the liquid vehicle. This shows that a high liquid load factor can be achieved in a liqui-pellet without compromising flowability. Overall, the results showed that the poor flowability of a liquisolid formulation could be overcomed with the liqui-pellet, which is believed to be a major advancement into the commercial feasibility of the liquisolid concept." @default.
• W2954071372 created "2019-07-12" @default.
• W2954071372 creator A5023571572 @default.
• W2954071372 creator A5035073798 @default.
• W2954071372 creator A5055400823 @default.
• W2954071372 date "2019-06-24" @default.
• W2954071372 modified "2023-10-13" @default.
• W2954071372 title "Liqui-Pellet: the Emerging Next-Generation Oral Dosage Form Which Stems from Liquisolid Concept in Combination with Pelletization Technology" @default.
• W2954071372 cites W1590254871 @default.
• W2954071372 cites W1954576198 @default.
• W2954071372 cites W1967724210 @default.
• W2954071372 cites W1968706872 @default.
• W2954071372 cites W1975509513 @default.
• W2954071372 cites W1989617745 @default.
• W2954071372 cites W1994041894 @default.
• W2954071372 cites W1994697384 @default.
• W2954071372 cites W1994893251 @default.
• W2954071372 cites W1997384329 @default.
• W2954071372 cites W2001312320 @default.
• W2954071372 cites W2010351913 @default.
• W2954071372 cites W2011773479 @default.
• W2954071372 cites W2011930026 @default.
• W2954071372 cites W2013852604 @default.
• W2954071372 cites W2015767901 @default.
• W2954071372 cites W2027464663 @default.
• W2954071372 cites W2031406133 @default.
• W2954071372 cites W2032646967 @default.
• W2954071372 cites W2037696353 @default.
• W2954071372 cites W2042479508 @default.
• W2954071372 cites W2046208687 @default.
• W2954071372 cites W2053900295 @default.
• W2954071372 cites W2054246330 @default.
• W2954071372 cites W2055444002 @default.
• W2954071372 cites W2057492682 @default.
• W2954071372 cites W2062209376 @default.
• W2954071372 cites W2064681790 @default.
• W2954071372 cites W2066927092 @default.
• W2954071372 cites W2076793884 @default.
• W2954071372 cites W2078839736 @default.
• W2954071372 cites W2079694316 @default.
• W2954071372 cites W2080768821 @default.
• W2954071372 cites W2082612497 @default.
• W2954071372 cites W2087050645 @default.
• W2954071372 cites W2087659180 @default.
• W2954071372 cites W2095214334 @default.
• W2954071372 cites W2105767281 @default.
• W2954071372 cites W2115439624 @default.
• W2954071372 cites W2135732933 @default.
• W2954071372 cites W2140067957 @default.
• W2954071372 cites W2156948134 @default.
• W2954071372 cites W2164125860 @default.
• W2954071372 cites W2166580946 @default.
• W2954071372 cites W2171601916 @default.
• W2954071372 cites W2195901151 @default.
• W2954071372 doi "https://doi.org/10.1208/s12249-019-1441-9" @default.
• W2954071372 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6591193" @default.
• W2954071372 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31236781" @default.
• W2954071372 hasPublicationYear "2019" @default.
• W2954071372 type Work @default.
• W2954071372 sameAs 2954071372 @default.
• W2954071372 citedByCount "22" @default.
• W2954071372 countsByYear W29540713722019 @default.
• W2954071372 countsByYear W29540713722020 @default.
• W2954071372 countsByYear W29540713722021 @default.
• W2954071372 countsByYear W29540713722022 @default.
• W2954071372 countsByYear W29540713722023 @default.
• W2954071372 crossrefType "journal-article" @default.
• W2954071372 hasAuthorship W2954071372A5023571572 @default.
• W2954071372 hasAuthorship W2954071372A5035073798 @default.
• W2954071372 hasAuthorship W2954071372A5055400823 @default.
• W2954071372 hasBestOaLocation W29540713721 @default.
• W2954071372 hasConcept C127413603 @default.
• W2954071372 hasConcept C142724271 @default.
• W2954071372 hasConcept C155574463 @default.
• W2954071372 hasConcept C159985019 @default.
• W2954071372 hasConcept C178790620 @default.
• W2954071372 hasConcept C17923525 @default.
• W2954071372 hasConcept C181389837 @default.
• W2954071372 hasConcept C185592680 @default.
• W2954071372 hasConcept C192562407 @default.
• W2954071372 hasConcept C204787440 @default.
• W2954071372 hasConcept C26771246 @default.
• W2954071372 hasConcept C2776964284 @default.
• W2954071372 hasConcept C2778115740 @default.
• W2954071372 hasConcept C2779849058 @default.
• W2954071372 hasConcept C42360764 @default.
• W2954071372 hasConcept C43617362 @default.
• W2954071372 hasConcept C56052488 @default.
• W2954071372 hasConcept C71924100 @default.
• W2954071372 hasConcept C77281830 @default.
• W2954071372 hasConcept C88380143 @default.
• W2954071372 hasConcept C98274493 @default.
• W2954071372 hasConceptScore W2954071372C127413603 @default.
• W2954071372 hasConceptScore W2954071372C142724271 @default.
• W2954071372 hasConceptScore W2954071372C155574463 @default.
• W2954071372 hasConceptScore W2954071372C159985019 @default.
• W2954071372 hasConceptScore W2954071372C178790620 @default.
• W2954071372 hasConceptScore W2954071372C17923525 @default.
• W2954071372 hasConceptScore W2954071372C181389837 @default.
• W2954071372 hasConceptScore W2954071372C185592680 @default.

• next